Subacute toxicity of Berberis vulgaris L Aqueous Extract in Atherosclerotic- induced Rabbit

Nurul Huda Mohd Nor

Abstract

Objective: Berberis vulgaris L is widely used in traditional medicine to treat various type of diseases. The evaluation of toxic properties of B. vulgaris L is crucial when considering public health protection because exposure to plant extracts can result in undesirable effects on consumers.

Method: In this study, the subacute oral toxicity of B. vulgaris aqueous extract was investigated in atherosclerotic-induced rabbit for ten weeks. This include to determine toxicity effect of BVAE on liver function test (alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase), renal function (urea and creatinine) and histopathological changes.

Result: Oral administration of aqueous extract at the dose of 25mg/kg and 50mg/kg for ten weeks resulted in no mortality or evidence of adverse effects, implying that B. vulgaris in nontoxic. there were no any significant elevations observed in the biochemical analysis of the blood serum. Further, histopathological examination revealed normal architecture and no significant adverse effects observed on the kidney and liver.

Conclusion: Overall, the results suggest that, the oral administration of B. vulgaris aqueous extract did not produce any significant toxic effect in atherosclerotic-induced rabbit. Hence, the extract can be utilized for pharmaceutical formulations at these concentrations.

 Full Text:

PDF

References

An, R.-B., Sohn, D.-H., & Kim, Y.-C. (2006). Hepatoprotective compounds of the roots of Cudrania tricuspidata on tacrine-induced cytotoxicity in Hep G2 cells. Biological and Pharmaceutical Bulletin, 29(4), 838-840.

Bilia, A., Giomi, M., Innocenti, M., Gallori, S., & Vincieri, F. (2008). HPLC–DAD–ESI–MS analysis of the constituents of aqueous preparations of verbena and lemon verbena and evaluation of the antioxidant activity. Journal of Pharmaceutical and Biomedical Analysis, 46(3), 463-470.

Burtis, C., and Ashwood, E. (1999). Tietz textbook of clinical chemistry and molecular Diagnostic(1st ed):Amsterdam:Elsevier Health Sci-ences.

Chi, L., Peng, L., Pan, N., Hu, X., & Zhang, Y. (2014). The anti-atherogenic effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1. International journal of molecular medicine, 34(4), 1087-1093.

El-Wahab, A. E. A., Ghareeb, D. A., Sarhan, E. E., Abu-Serie, M. M., & El Demellawy, M. A. (2013). In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. Com-plementary and Alternative Medicine, 13(1), 218.

Fitzgerald, M. A. (2000). What are the reasons for an elevated alkaline phosphatase? . http://www.medscape.com/viewarticle/413420

Hadaruga, D. I., Hadaruga, N. G., Bandur, G. N., Rivis, A., Costescu, C., Ordodi, V. L., & Ardelean, A. (2010). Berberis vulgaris ex-tract/β cyclodextrin nanoparticles synthesis and characterization. Revista de Chimie (Bucharest), 61(1), 669-675.

Hoekstra, L. T., de Graaf, W., Nibourg, G. A., Heger, M., Bennink, R. J., Stieger, B., & van Gulik, T. M. (2013). Physiological and bio-chemical basis of clinical liver function tests: a review. Annals of surgery, 257(1), 27-36.

Imanshahidi, M., & Hosseinzadeh, H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, ber-berine. Phytotherapy Research, 22(8), 999-1012.

Imenshahidi, M., & Hosseinzadeh, H. (2016). Berberis Vulgaris and Berberine: An Update Review. Phytotherapy Research, 1(2).

Ivanovska, N., & Philipov, S. (1996). Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. International journal of immunopharmacology, 18(10), 553-561.

Javadzadeh, S. M., & Fallah, S. R. (2012). Therapeutic application of different parts berberis vulgaris. International Journal of Agriculture and Crop Sciences, 4, 404-408.

Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., . . . Wollman, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1(5), 431-435.

Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., and Eknoyan, G. (2003). National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Annals of In-ternal Medicine, 139(2), 137-147.

Mahmoudvand, H., Sharififar, F., Sharifi, I., Ezatpour, B., Harandi, M. F., Makki, M. S., . . . Jahanbakhsh, S. (2014). In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, berberine against different Leishmania species. Iranian journal of parasitology, 9(1), 28.

Mohammadi, A., Sahebkar, A., Kermani, T., Zhilaee, M., Tavallaie, S., & Mobarhan, M. G. (2014). Barberry administration and pro-oxidant–antioxidant balance in patients with metabolic syndrome. Iranian Red Crescent Medical Journal, 16(12).

Motalleb, G., Hanachi, P., Fauziah, O., & Asmah, R. (2012). Effect of Berberis vulgaris fruit extract on alpha-fetoprotein gene expression and chemical carcinogen metabolizing enzymes activities in hepatocarcinogenesis rats. Iranian Journal of Cancer Prevention, 1(1), 33-42.

Ramli, N. (2005). Ethanol induced kidney morphological changes in rats after acute dosing. (Master), Universiti Putra Malaysia,

Rosenfeld, M. E., & Ross, R. (1990). Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and compara-bly hypercholesterolemic fat-fed rabbits. Arteriosclerosis, thrombosis, and vascular biology, 10(5), 680-687.

Saedi, T. A. (2015). Anti-Leukaemic And Chemotherapy Supportive Effects Of Berberis Vulgaris L. Fruit Crude Extract On In Vitro And In Vivo Models Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, in Fulfillment of Requirements for the Degree of Doctor of Philosophy. Retrieved from https://core.ac.uk/download/pdf/158575778.pdf

Soma, M. R., Natali, M., Donetti, E., Baetta, R., Farina, P., Leonardi, A., . . . Catapano, A. L. (2009). Effect of lercanidipine and its (R)‐enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits. British journal of pharmacology, 125(7), 1471-1476.

Srivastava, K., Bordia, A., & Verma, S. (1995). Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins, leukotrienes and essential fatty acids, 52(4), 223-227.

Suau, R., Rico, R., López-Romero, J. M., Nájera, F., & Cuevas, A. (1998). Isoquinoline alkaloids from Berberis vulgaris subsp. australis. Phytochemistry, 49(8), 2545-2549.

Zarei, A., Changizi-Ashtiyani, S., Taheri, S., & Ramezani, M. (2015). A quick overview on some aspects of endocrinological and therapeu-tic effects of Berberis vulgaris L. Avicenna journal of phytomedicine, 5(6), 485.

Refbacks

  • There are currently no refbacks.